Cargando…

2510. Systematic Literature Review of Multiclass Resistance in Heavily Treatment Experienced Persons with HIV

BACKGROUND: Because of progress in antiretroviral therapy (ART), fewer people with HIV experience virologic failure with multiclass resistance. We sought to estimate the prevalence of multiclass resistance since the introduction of INSTI-based regimens using a systematic literature review. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mauskopf, Josephine, Fernandez, Maria M, Ghosn, Jade, Sax, Paul, Priest, Julie, Garris, Cindy, Clark, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809874/ http://dx.doi.org/10.1093/ofid/ofz360.2188

Ejemplares similares

Characterization of Heavily Treatment-Experienced People With HIV and Impact on Health Care Resource Utilization in US Commercial and Medicare Advantage Health Plans
por: Priest, Julie, et al.
Publicado: (2021)

HIV: how to manage heavily treatment-experienced patients
por: Spivack, Stephanie, et al.
Publicado: (2022)

2510 Disparities in navigation to health research among Floridians
por: Cottler, Linda B., et al.
Publicado: (2018)

Observation of a spin-6 neutral meson r(2510)
por: Binon, Freddy G, et al.
Publicado: (1983)

2510: QIPR: Creating a Quality Improvement Project Registry
por: Allen, Amber L., et al.
Publicado: (2018)

Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes
por: Hsu, Ricky K., et al.
Publicado: (2023)

Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients
por: Yun, Hu, et al.
Publicado: (2020)

2510. Adapting the CDC HCV viral clearance cascade methodology for persons with HIV (PWH) and HCV co-infection in 5 Health Department Jurisdictions in the US
por: Wegener, Maximilian D, et al.
Publicado: (2023)

Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapy
por: Gaytán-Martínez, JE, et al.
Publicado: (2010)

Sustained HIV Viral Suppression With Dolutegravir, Tenofovir, and Emtricitabine as Initial Therapy Despite High-Level Transmitted Multiclass Resistance
por: Nagami, Ellen H, et al.
Publicado: (2021)

Prevalence and incidence of hypertension in a heavily treatment-experienced cohort of people living with HIV in Uganda
por: Byonanebye, Dathan M., et al.
Publicado: (2023)

Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1
por: Aberg, Judith A., et al.
Publicado: (2023)

Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1
por: Ackerman, Peter, et al.
Publicado: (2021)

Prognostic and clinicopathological significance of long noncoding RNA CTD-2510F5.4 in gastric cancer
por: Wang, Zhe, et al.
Publicado: (2018)

PB2510: CHARACTERISATION OF SICKLE CELL DISEASE PATIENTS: A PORTUGUESE REAL-WORLD STUDY (ASCEND)
por: Deveza, Maria Manuel, et al.
Publicado: (2023)

Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals
por: Anderson, Sarah-Jane, et al.
Publicado: (2021)

Opening the door on entry inhibitors in HIV: Redefining the use of entry inhibitors in heavily treatment experienced and treatment‐limited individuals living with HIV
por: Orkin, Chloe, et al.
Publicado: (2022)

1254. An Increase in Single-tablet Regimen (STR) Utilization for People Living with HIV (PLWH) Enrolled in Medicaid had Minimal Impact on Pharmacy Costs
por: Brogan, Andrew P, et al.
Publicado: (2022)

Use of dolutegravir in two INI-experienced patients with multiclass resistance resulted in excellent virological and immunological responses
por: Marije Hofstra, Laura, et al.
Publicado: (2014)

multiclassPairs: an R package to train multiclass pair-based classifier
por: Marzouka, Nour-Al-Dain, et al.
Publicado: (2021)

1255. Single-tablet Regimens (STR) Offer Better Persistence and Adherence, with Lower Costs by Adherence Status, than Multiple-tablet Regimens (MTR) for People Living with HIV (PLWH) Enrolled in Medicaid
por: Brogan, Andrew P, et al.
Publicado: (2022)

Phase I and II Study of Gemcitabine and Vinorelbine in Heavily Pretreated Patients with Metastatic Breast Cancer and Review of the Literature
por: Abdayem, Pamela, et al.
Publicado: (2014)

2510. Epidemiological Change of Cytomegalovirus Diseases in the Developed Country With High Cytomegalovirus–Seropositive Rate: Nationwide, Whole Population-Based Study
por: Yoo, Seul Gi, et al.
Publicado: (2018)

Week 96 Genotypic and Phenotypic Results of the Fostemsavir Phase 3 BRIGHTE Study in Heavily Treatment-Experienced Adults Living with Multidrug-Resistant HIV-1
por: Gartland, Margaret, et al.
Publicado: (2022)

2512. Decreasing Adherence to Antiretroviral Therapy over 4 Years of Follow-up in a Commercially-Insured Population of Patients with HIV
por: Priest, Julie, et al.
Publicado: (2019)

Multiclass discovery in array data
por: Liu, Yingchun, et al.
Publicado: (2004)

2500. Fostemsavir Drug–Drug Interaction Profile, an Attachment Inhibitor and Oral Prodrug of Temsavir, for Heavily Treatment Experienced HIV-1-Infected Patients
por: Moore, Katy P, et al.
Publicado: (2019)

1585. Efficacy and safety of long-acting subcutaneous lenacapavir in heavily treatment-experienced people with multi-drug resistant HIV: Week 52 results
por: Ogbuagu, Onyema, et al.
Publicado: (2022)

Optimizing Antiretroviral Therapy in Heavily ART-Experienced Patients with Multi-Class Resistant HIV-1 Using Proviral DNA Genotypic Resistance Testing
por: Rauschning, Dominic, et al.
Publicado: (2023)

1596. Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multi-Drug Resistant HIV: Week 104 Results
por: Ogbuagu, Onyema, et al.
Publicado: (2023)

2502. Impact of Pharmacist-Led Antiretroviral Therapy Simplification Initiative in Heavily Treatment-Experienced Patients on Virologic Control
por: Jimenez, Humberto R, et al.
Publicado: (2019)

834. Characterization of Heavily Treatment Experienced HIV-1 Infected Clinical Trial Participants Infected with SARS-CoV-2 COVID 19: Fostemsavir BRIGHTE Phase 3 Clinical Trial
por: Chabria, Shiven, et al.
Publicado: (2021)

Risk calculation charts for multiclass prediction models
por: Van Belle, Vanya, et al.
Publicado: (2015)

Multiclass Classification Based on Combined Motor Imageries
por: Lindig-León, Cecilia, et al.
Publicado: (2020)

Heavily doped semiconductors
por: Fistul’, Victor I
Publicado: (1995)

Gene Selection for Multiclass Prediction by Weighted Fisher Criterion
por: Xuan, Jianhua, et al.
Publicado: (2007)

Prediagnosis of Obstructive Sleep Apnea via Multiclass MTS
por: Su, Chao-Ton, et al.
Publicado: (2012)

The Generalization Error Bound for the Multiclass Analytical Center Classifier
por: Fanzi, Zeng, et al.
Publicado: (2013)

Enhancing Confusion Entropy (CEN) for binary and multiclass classification
por: Delgado, Rosario, et al.
Publicado: (2019)

Mexican Hat Wavelet Kernel ELM for Multiclass Classification
por: Wang, Jie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_br45emc74bei4rlbl8kli8d872